Okun Michael S, Wu Samuel S, Fayad Sarah, Ward Herbert, Bowers Dawn, Rosado Christian, Bowen Lauren, Jacobson Charles, Butson Christopher, Foote Kelly D
Department of Neurology, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, Gainesville, FL, United States of America; Department of Neurosurgery, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, Gainesville, FL, United States of America.
Department of Biostatistics, Center for Movement Disorders and Neurorestoration, University of Florida, Gainesville, Gainesville, FL, United States of America.
PLoS One. 2014 Dec 3;9(12):e114140. doi: 10.1371/journal.pone.0114140. eCollection 2014.
To study mood and behavioral effects of unilateral and staged bilateral subthalamic nucleus (STN) and globus pallidus internus (GPi) deep brain stimulation (DBS) for Parkinson's disease (PD).
There are numerous reports of mood changes following DBS, however, most have focused on bilateral simultaneous STN implants with rapid and aggressive post-operative medication reduction.
A standardized evaluation was applied to a subset of patients undergoing STN and GPi DBS and who were also enrolled in the NIH COMPARE study. The Unified Parkinson Disease Rating Scale (UPDRS III), the Hamilton depression (HAM-D) and anxiety rating scales (HAM-A), the Yale-Brown obsessive-compulsive rating scale (YBOCS), the Apathy Scale (AS), and the Young mania rating scale (YMRS) were used. The scales were repeated at acute and chronic intervals. A post-operative strategy of non-aggressive medication reduction was employed.
Thirty patients were randomized and underwent unilateral DBS (16 STN, 14 GPi). There were no baseline differences. The GPi group had a higher mean dopaminergic dosage at 1-year, however the between group difference in changes from baseline to 1-year was not significant. There were no differences between groups in mood and motor outcomes. When combining STN and GPi groups, the HAM-A scores worsened at 2-months, 4-months, 6-months and 1-year when compared with baseline; the HAM-D and YMRS scores worsened at 4-months, 6-months and 1-year; and the UPDRS Motor scores improved at 4-months and 1-year. Psychiatric diagnoses (DSM-IV) did not change. No between group differences were observed in the cohort of bilateral cases.
There were few changes in mood and behavior with STN or GPi DBS. The approach of staging STN or GPi DBS without aggressive medication reduction could be a viable option for managing PD surgical candidates. A study of bilateral DBS and of medication reduction will be required to better understand risks and benefits of a bilateral approach.
研究单侧及分期双侧丘脑底核(STN)和内侧苍白球(GPi)深部脑刺激(DBS)治疗帕金森病(PD)对情绪和行为的影响。
有许多关于DBS后情绪变化的报道,然而,大多数研究集中在双侧同时植入STN且术后迅速大幅减少用药的情况。
对接受STN和GPi DBS且参加美国国立卫生研究院(NIH)COMPARE研究的部分患者进行标准化评估。使用统一帕金森病评定量表(UPDRS III)、汉密尔顿抑郁量表(HAM-D)、汉密尔顿焦虑量表(HAM-A)、耶鲁-布朗强迫量表(YBOCS)、淡漠量表(AS)和杨氏躁狂量表(YMRS)。在急性和慢性阶段重复使用这些量表。采用术后不激进的减药策略。
30例患者被随机分组并接受单侧DBS(16例STN,14例GPi)。基线无差异。GPi组在1年时平均多巴胺能药物剂量较高,但从基线到1年的组间变化差异不显著。两组在情绪和运动结果方面无差异。将STN和GPi组合并后,与基线相比,HAM-A评分在2个月、4个月、6个月和1年时恶化;HAM-D和YMRS评分在4个月、6个月和1年时恶化;UPDRS运动评分在4个月和1年时改善。精神疾病诊断(DSM-IV)未改变。双侧病例队列中未观察到组间差异。
STN或GPi DBS对情绪和行为影响较小。分期进行STN或GPi DBS且不激进减药的方法可能是管理PD手术候选患者的可行选择。需要对双侧DBS和减药进行研究,以更好地了解双侧治疗方法的风险和益处。